Search research articles
Contact Us
Filters
Showing results (21-30 of 266) with videos related to
Page
of 27
Sort By:
The Oncologist
|
February 3, 2011
The role of RANK-ligand inhibition in cancer: the story of denosumab
Daniel Castellano, Juan Manuel Sepulveda, Ignacio García-Escobar, et al.
Cancer Treatment Reviews
|
July 14, 2020
Exposure-response modeling of cabozantinib in patients with renal cell carcinoma: Implications for patient care
Daniel Castellano, Jose Pablo Maroto, Fawzi Benzaghou, et al.
Seminars in Oncology
|
February 7, 2003
Pemetrexed in bladder, head and neck, and cervical cancers
Luis Paz-Ares, Eva Ciruelos, Rocío García-Carbonero, et al.
Metabolism: Clinical and Experimental
|
December 17, 2020
Human adipose tissue-derived stem cell paracrine networks vary according metabolic risk and after TNFα-induced death: An analysis at the single-cell level
Wilfredo Oliva-Olivera, Daniel Castellano-Castillo, Ferdinand von Meyenn, et al.
The Oncologist
|
December 25, 2012
Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study
Daniel Castellano, Emilio Bajetta, Ashok Panneerselvam, et al.
Oncotarget
|
February 2, 2022
Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
Ignacio Durán, Daniel Castellano, Javier Puente, et al.
Expert Opinion on Pharmacotherapy
|
June 16, 2011
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
Daniel Castellano, José L González-Larriba, Luis M Antón-Aparicio, et al.
Therapeutic Advances in Medical Oncology
|
July 18, 2022
Cabozantinib for the treatment of solid tumors: a systematic review
Pablo Maroto, Camillo Porta, Jaume Capdevila, et al.
Biomedicines
|
October 23, 2021
Genome Profiling of H3k4me3 Histone Modification in Human Adipose Tissue during Obesity and Insulin Resistance
Daniel Castellano-Castillo, Bruno Ramos-Molina, Wilfredo Oliva-Olivera, et al.
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
Daniel Castellano, Andrea B Apolo, Camillo Porta, et al.
Page
of 27
Search research articles
Search
Showing results (21-30 of 266) with videos related to
Sort By:
Page
of 27
The Oncologist
|
February 3, 2011
The role of RANK-ligand inhibition in cancer: the story of denosumab
Daniel Castellano, Juan Manuel Sepulveda, Ignacio García-Escobar, et al.
Cancer Treatment Reviews
|
July 14, 2020
Exposure-response modeling of cabozantinib in patients with renal cell carcinoma: Implications for patient care
Daniel Castellano, Jose Pablo Maroto, Fawzi Benzaghou, et al.
Seminars in Oncology
|
February 7, 2003
Pemetrexed in bladder, head and neck, and cervical cancers
Luis Paz-Ares, Eva Ciruelos, Rocío García-Carbonero, et al.
Metabolism: Clinical and Experimental
|
December 17, 2020
Human adipose tissue-derived stem cell paracrine networks vary according metabolic risk and after TNFα-induced death: An analysis at the single-cell level
Wilfredo Oliva-Olivera, Daniel Castellano-Castillo, Ferdinand von Meyenn, et al.
The Oncologist
|
December 25, 2012
Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study
Daniel Castellano, Emilio Bajetta, Ashok Panneerselvam, et al.
Oncotarget
|
February 2, 2022
Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
Ignacio Durán, Daniel Castellano, Javier Puente, et al.
Expert Opinion on Pharmacotherapy
|
June 16, 2011
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
Daniel Castellano, José L González-Larriba, Luis M Antón-Aparicio, et al.
Therapeutic Advances in Medical Oncology
|
July 18, 2022
Cabozantinib for the treatment of solid tumors: a systematic review
Pablo Maroto, Camillo Porta, Jaume Capdevila, et al.
Biomedicines
|
October 23, 2021
Genome Profiling of H3k4me3 Histone Modification in Human Adipose Tissue during Obesity and Insulin Resistance
Daniel Castellano-Castillo, Bruno Ramos-Molina, Wilfredo Oliva-Olivera, et al.
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
Daniel Castellano, Andrea B Apolo, Camillo Porta, et al.
Page
of 27